| Antidiabetic effect of brain‐derived neurotrophic factor and its association with inflammation in type 2 diabetes mellitus C Eyileten, A Kaplon-Cieslicka, D Mirowska-Guzel, L Malek, M Postula Journal of diabetes research 2017 (1), 2823671, 2017 | 214 | 2017 |
| MicroRNAs as diagnostic and prognostic biomarkers in ischemic stroke—a comprehensive review and bioinformatic analysis C Eyileten, Z Wicik, S De Rosa, D Mirowska-Guzel, A Soplinska, C Indolfi, ... Cells 7 (12), 249, 2018 | 166 | 2018 |
| Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review J Pordzik, D Jakubik, J Jarosz-Popek, Z Wicik, C Eyileten, S De Rosa, ... Cardiovascular diabetology 18, 1-19, 2019 | 142 | 2019 |
| The relation of the brain-derived neurotrophic factor with microRNAs in neurodegenerative diseases and ischemic stroke C Eyileten, L Sharif, Z Wicik, D Jakubik, J Jarosz-Popek, A Soplinska, ... Molecular neurobiology 58 (1), 329-347, 2021 | 127 | 2021 |
| Genome-wide association study using pooled DNA to identify candidate markers mediating susceptibility to postoperative nausea and vomiting PK Janicki, R Vealey, J Liu, J Escajeda, M Postula, K Welker The Journal of the American Society of Anesthesiologists 115 (1), 54-64, 2011 | 113 | 2011 |
| The potential role of platelet-related microRNAs in the development of cardiovascular events in high-risk populations, including diabetic patients: a review J Pordzik, K Pisarz, S De Rosa, AD Jones, C Eyileten, C Indolfi, L Malek, ... Frontiers in endocrinology 9, 74, 2018 | 108 | 2018 |
| Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups G Gelbenegger, M Postula, L Pecen, S Halvorsen, M Lesiak, ... BMC medicine 17, 1-16, 2019 | 97 | 2019 |
| Subclinical leaflet thrombosis after transcatheter aortic valve replacement: a meta-analysis M Bogyi, RE Schernthaner, C Loewe, GM Gager, AM Dizdarevic, ... Cardiovascular Interventions 14 (24), 2643-2656, 2021 | 96 | 2021 |
| ACE2 interaction networks in COVID-19: a physiological framework for prediction of outcome in patients with cardiovascular risk factors Z Wicik, C Eyileten, D Jakubik, SN Simões, DC Martins Jr, R Pavão, ... Journal of clinical medicine 9 (11), 3743, 2020 | 94 | 2020 |
| Baseline platelet size is increased in patients with acute coronary syndromes developing early stent thrombosis and predicts future residual platelet reactivity. A case-control … Z Huczek, KJ Filipiak, J Kochman, M Michalak, M Roik, R Piatkowski, ... Thrombosis Research 125 (5), 406-412, 2010 | 94 | 2010 |
| MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics D Jakubik, A Fitas, C Eyileten, J Jarosz-Popek, A Nowak, P Czajka, ... Cardiovascular diabetology 20, 1-29, 2021 | 77 | 2021 |
| Effects of environmental factors on severity and mortality of COVID-19 D Kifer, D Bugada, J Villar-Garcia, I Gudelj, C Menni, C Sudre, F Vučković, ... Frontiers in medicine 7, 607786, 2021 | 70 | 2021 |
| Ticagrelor–toward more efficient platelet inhibition and beyond MJ Kubisa, MP Jezewski, A Gasecka, JM Siller-Matula, M Postuła Therapeutics and clinical risk management, 129-140, 2018 | 70 | 2018 |
| Early biomarkers of neurodegenerative and neurovascular disorders in diabetes A Gasecka, D Siwik, M Gajewska, MJ Jaguszewski, T Mazurek, KJ Filipiak, ... Journal of Clinical Medicine 9 (9), 2807, 2020 | 69 | 2020 |
| Genetic determinants of platelet reactivity during acetylsalicylic acid therapy in diabetic patients: evaluation of 27 polymorphisms within candidate genes M Postula, A Kaplon‐Cieslicka, M Rosiak, A Kondracka, A Serafin, ... Journal of Thrombosis and Haemostasis 9 (11), 2291-2301, 2011 | 59 | 2011 |
| Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel A Gasecka, R Nieuwland, M Budnik, F Dignat‐George, C Eyileten, ... Journal of thrombosis and haemostasis 18 (3), 609-623, 2020 | 53 | 2020 |
| Novel antiplatelet agents in the prevention of cardiovascular complications–focus on ticagrelor MM Marczewski, M Postula, D Kosior Vascular health and risk management, 419-429, 2010 | 51 | 2010 |
| Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome GM Gager, B Biesinger, F Hofer, MP Winter, C Hengstenberg, B Jilma, ... Vascular Pharmacology 135, 106806, 2020 | 46 | 2020 |
| Effects of SGLT2 inhibitors on ion homeostasis and oxidative stress associated mechanisms in heart failure GM Gager, D von Lewinski, H Sourij, B Jilma, C Eyileten, K Filipiak, ... Biomedicine & Pharmacotherapy 143, 112169, 2021 | 45 | 2021 |
| Cardiovascular outcome in patients treated with SGLT2 inhibitors for heart failure: a meta-analysis GM Gager, G Gelbenegger, B Jilma, D Von Lewinski, H Sourij, C Eyileten, ... Frontiers in cardiovascular medicine 8, 691907, 2021 | 42 | 2021 |
